<img height="1" width="1" style="display:none;" alt="" src="https://dc.ads.linkedin.com/collect/?pid=412980&amp;fmt=gif">

 Longevity Leaders World Congress White Transparent 330x


AGEING SCIENCE | AGEING WELL | LONGEVITY RISK


2nd Annual Congress
21-22 April 2020
133 Houndsditch Liverpool St. | London | UK

#longevityleaders
@longevityleader

Created by    LSX Logo

DOWNLOAD BROCHURE

The congress for leaders in longevity science, technology, business and finance

  

‘This is time well spent… in terms of getting yourself properly immersed into what is possibly the most important debate in policy for the next 5-10 years’
Wilf Blackburn, Chief Executive Officer, Prudential Assurance Company Singapore

Why the Longevity Leaders World Congress?

Around the world our populations are ageing. 

By 2050 there will be more people aged 60 or over than aged 10-24 globally. Their global spending power is estimated to be worth up to $17tn USD. Those 60+ year olds are likely to be the primary carers for their 90+ parents.

Our understanding of biological ageing processes is improving and set to dramatically change how we manage the diseases of ageing. Life expectancy improvements are driving a thriving market in bulk annuities and longevity swaps. Wherever you play, ageing is having an impact.

The Longevity Leaders World Congress is the definitive global meeting with the mission of extending human health span, delivering healthy ageing and financial wellness in the context of longevity.

As three-conferences-in-one, it digs deeply into each facet while shared plenary and networking sessions provide opportunities for interdisciplinary exchange.

Ageing Science | Ageing Well | Longevity Risk

Longevity Leaders World Congress

5

tracks

150+

speakers

500+

attendees

1000+

meetings

60

start-up showcases

4

CEO forums

Congress at a Glance

Day 1: 21st April

09:00


Plenary Keynotes

11:30


Ageing Science


Ageing Well


Longevity Risk


Biotech Showcase


Age-Tech Showcase

13:00


Biotech CEO Forum


Poster Session I

14:30


The Science Of Ageing Conference


Ageing Well


Longevity Risk


Biotech Showcase


Age-Tech Showcase

16:00


Corporate CEO Forum


Pensions Forum

16:30


Ageing Science


Ageing Well


Longevity Risk


Biotech Showcase


Age-Tech Showcase

18:00


Networking Drinks

09:00 - 18:00

Exhibition
&
1-2-1 Partnering

Day 2: 22nd April

09:00


Ageing Science


Ageing Well


Longevity Risk


Biotech Showcase


Age-Tech Showcase

13:00


Poster Session II

14:30


Ageing Science


Ageing Well


Risk Forum


Biotech Showcase


Age-Tech Showcase

16:30


Closing Plenary

18:00


Close


09:00 - 18:00

Exhibition
&
1-2-1 Partnering

Advisory Board

Ageing Science 

James Peyer, CEO, Apollo Ventures
James Peyer
CEO
Apollo Ventures
Aubrey de Grey, CSO, SENS Research Foundation; VP, AgeX Therapeutics
Aubrey de Grey
CSO, SENS Research Foundation;
VP, AgeX Therapeutics
Tristan Edward, CEO, Life Biosciences
Tristan Edwards
CEO
Life Biosciences
Sree Kant, Head of Business Development, Life Biosciences
Sree Kant
Head of Business Development
Life Biosciences
Joao Pedro de Magalhaes, Scientist and Futurist, University of Liverpool
Joao Pedro de Magalhaes
Scientist and Futurist
University of Liverpool
Mark Allen, CEO, Elevian
Mark Allen
CEO
Elevian
Sergey Young, Founder, Longevity Vision Fund
Sergey Young
Founder
Longevity Vision Fund
Lynne Cox, Associate Professor, University of Oxford
Lynne Cox
Associate Professor
University of Oxford

Ageing Well And Risk

John Godfrey, Head of Corporate Affairs, Legal and General
John Godfrey
Head of Corporate Affairs
Legal and General
Wilf Blackburn, CEO, Prudential Singapore
Wilf Blackburn
CEO
Prudential Singapore
Steven Baxter, Head of Longevity Research, Hymans
Steven Baxter
Head of Longevity Research
Hymans
Dominic Endicott, CEO, 4Gen Ventures
Dominic Endicott
CEO
4Gen Ventures
Tina Woods, CEO, Collider Health
Tina Woods
CEO
Collider Health
Paul Gaudin, CEO, CareRooms
Paul Gaudin
CEO
CareRooms
Andrew Fried, Life Sciences Global Industry Leader, IBM
Andrew Fried
Life Sciences Global Industry Leader
IBM
Joe Tighe, Head of Strategy, Benevolent AI
Joe Tighe
Head of Strategy
Benevolent AI